INTERLEUKIN-1 RECEPTOR ANTAGONIST IN HUMAN EPIDERMIS AND CULTURED KERATINOCYTES

被引:39
作者
GRUAZCHATELLARD, D
BAUMBERGER, C
SAURAT, JH
DAYER, JM
机构
[1] HOP CANTONAL GENEVA, DERMATOL CLIN, CH-1211 GENEVA 4, SWITZERLAND
[2] HOP CANTONAL GENEVA, DEPT MED, DIV IMMUNOL & ALLERGY, CH-1211 GENEVA 4, SWITZERLAND
来源
FEBS LETTERS | 1991年 / 294卷 / 1-2期
关键词
KERATINOCYTE; HUMAN EPIDERMIS; INTERLEUKIN-1; INTERLEUKIN-1 RECEPTOR ANTAGONIST;
D O I
10.1016/0014-5793(91)81360-K
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin 1 (IL-1), present in high amounts in normal human skin without any sign of inflammation, suggests a complex mechanism by which its bioactivity is regulated. The specific receptor antagonist of IL-1 (IL-1 ra) was analyzed in human skin, sweat and cultured keratinocytes. Extracts of both skin and cultured keratinocytes blocked the binding of [I-125]IL-1 to its receptor whereas sweat did not. The inhibitory activity was cell-associated, was not secreted by cultured keratinocytes, and IL-1 ra mRNA was identified in these cells. There was an inverse relationship between the level of IL-1 ra and that of IL-1-alpha and beta since extracts of differentiating keratinocytes (DK) and higher IL-1 ra levels and expressed more mRNA for IL-1 ra than non-differentiated keratinocytes (NDK), whereas NDK contained 4 times more IL-1-alpha and beta-proteins than DK. This association of cell differentiation with a shift in agonist/antagonist ratio might be related to important autocrine or paracrine functions of IL-1 in normal and inflamed human skin.
引用
收藏
页码:137 / 140
页数:4
相关论文
共 24 条
  • [1] AREND WP, 1989, J IMMUNOL, V143, P1851
  • [2] PROSTAGLANDIN-E2 AND COLLAGENASE PRODUCTION BY FIBROBLASTS AND SYNOVIAL-CELLS IS REGULATED BY URINE-DERIVED HUMAN INTERLEUKIN-1 AND INHIBITOR(S)
    BALAVOINE, JF
    DEROCHEMONTEIX, B
    WILLIAMSON, K
    SECKINGER, P
    CRUCHAUD, A
    DAYER, JM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (04) : 1120 - 1124
  • [3] BIGLER CF, 1991, P NATL ACAD SCI USA, V88, P3681
  • [4] COOPER KD, 1990, J IMMUNOL, V144, P4593
  • [5] DAYER JM, 1989, INTERLEUKIN 1 INFLAM, V16, P233
  • [6] DEMCZUK S, 1988, J BIOL CHEM, V263, P13039
  • [7] DIDERJEAN L, 1990, CYTOKINE, V2, P438
  • [8] LOCALIZATION AND CHARACTERIZATION OF THE INTERLEUKIN-1 IMMUNOREACTIVE POOL (IL-1 ALPHA AND BETA FORMS) IN NORMAL HUMAN-EPIDERMIS
    DIDIERJEAN, L
    SALOMON, D
    MEROT, Y
    SIEGENTHALER, G
    SHAW, A
    DAYER, JM
    SAURAT, JH
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1989, 92 (06) : 809 - 816
  • [9] DINARELLO CA, 1989, ADV IMMUNOL, V44, P153, DOI [10.1016/s0065-2776(08)60642-2, 10.1016/S0065-2776(08)60642-2, DOI 10.1016/S0065-2776(08)60642-2]
  • [10] PRIMARY STRUCTURE AND FUNCTIONAL EXPRESSION FROM COMPLEMENTARY-DNA OF A HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST
    EISENBERG, SP
    EVANS, RJ
    AREND, WP
    VERDERBER, E
    BREWER, MT
    HANNUM, CH
    THOMPSON, RC
    [J]. NATURE, 1990, 343 (6256) : 341 - 346